Study of ES414 in Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT02262910 · COMPLETED

Trial details

NCT number: NCT02262910
Sponsor: Aptevo Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2015-01-01
Primary completion: 2018-12-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.